Key result
Guided growth of the trochanteric apophysis combined with soft tissue release improved pain, limp, and Trendelenburg sign in 11 of 12 patients (91.7%) at an average follow-up of 49 months.
Why the study?
Does guided growth of the trochanteric apophysis combined with soft tissue release improve clinical and radiographic outcomes in children with Legg-Calve-Perthes disease?
Population
12 children (9 boys, 3 girls) with Legg-Calve-Perthes disease, average age 7.3 years (range 5.3-9.7).
Design
Case_series
Follow-up
average 49 months (range 14-78 months)
Authors
Loading...
May improve symptoms in Legg-Calve-Perthes disease; leaves open need for controlled trials before adoption.
Observational (n=12)
Does guided growth of the trochanteric apophysis combined with soft tissue release improve clinical and radiographic outcomes in children with Legg-Calve-Perthes disease?
Guided growth of the trochanteric apophysis combined with soft tissue release may improve pain and gait in children with Legg-Calve-Perthes disease while avoiding iatrogenic varus deformity.
Gililland et al. (2014) conducted an observational in Legg-Calve-Perthes disease (n=12). Guided growth of the trochanteric apophysis combined with soft tissue release was evaluated on Improvement in pain, and alleviation of limp and Trendelenburg sign. Guided growth of the trochanteric apophysis combined with soft tissue release improved pain, limp, and Trendelenburg sign in 11 of 12 patients (91.7%) at an average follow-up of 49 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: